78.78 USD
↗ 1.38 (1.78%)AT CLOSE (11:59 AM EDT)
Haemonetics Corporation
HAENYSE • USD
77.93
↘ 0.85 (1.08%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
77.93
↘ 0.85 (1.08%)
Market: CLOSED
Haemonetics Corporation (HAE) is currently trading at $78.78. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a weak Piotroski F-Score of 2/9, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, HAE trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jul 24, 2026.
Open?$78.32
High?$79.41
Low?$77.27
Prev. Close?$77.40
Volume?462.7K
Avg. Volume?779.1K
VWAP?$78.89
Rel. Volume?0.59x
Bid / Ask
Bid?$62.00 × 100
Ask?$85.00 × 100
Spread?$23.00
Midpoint?$73.50
Valuation & Ratios
Market Cap?3.6B
Shares Out?45.4M
Float?45.8M
Float %?98.6%
P/E Ratio?36.79
P/B Ratio?4.50
EPS?$2.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Employees
3.0K
Market Cap
3.6B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
1991-05-09
Address
125 SUMMER STREET
BOSTON, MA 02110
Phone: (781) 848-7100
BOSTON, MA 02110
Phone: (781) 848-7100
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?56
Momentum?73
Short Sent.?74
Piotroski F-Score?2/9Weak
Altman Z-Score?2.56Grey
Confidence?62%Moderate
Short InterestElevated
Short % of Float?5.90%Elevated
Short Interest?2.7M
Days to Cover?4.2
Free Float45.8M
Avg Daily Volume640.8K
Settlement Date2026-07-15
Financial Health
Current Ratio?2.95Strong
Quick Ratio?1.87Adequate
Cash Ratio?0.87Adequate
Debt/Equity?1.54High
ValuationFAIRLY VALUEDvs 8 peers + S&P 500
Score72/100
P/E?36.8PRICEY▾
Peers43
S&P20
P/B?4.50FAIR▾
Peers56
S&P40
P/S?2.68CHEAP▾
Peers78
S&P55
P/FCF?17.2CHEAP▾
Peers86
S&P66
EV/EBITDA?12.8FAIR▾
Peers86
S&P63
EV/Sales?3.42FAIR▾
Peers78
S&P55
Returns & Efficiency
ROE?12.2%STRONG▾
Peers57
S&P44
ROA?4.1%FAIR▾
Peers29
S&P37
Cash Flow & Enterprise
FCF?$208.6M
Enterprise Value?$4.6B
Fundamentals ratios updated end of day